US medtech group lauds Japan's assurance on accelerating reviews
This article was originally published in RAJ Devices
Executive Summary
A report of the US-Japan Regulatory Reform and Competition Policy Initiative outlines a host of measures that Japanese regulators have initiated recently or that are in the pipeline to accelerate their review of pharmaceuticals and medical devices and enhance Japanese patient access to US medical technology1-3.